ARS Pharmaceuticals, Inc. (SPRY) P/E Ratio

PE Ratio:

N/A
October 16, 2025

Summary

  • SPRY price to earnings ratio is not available.

Performance

SPRY PE Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

OtherSPRYvaluation metrics

PE Ratio Formula

P/E =  
Price
TTM Earnings Per Share

SPRY PE Ratio Trends

PeriodPeriodPE RatioPE RatioPricePriceTTM EPSTTM EPSTTM RevenueTTM Revenue
1D1 Day--7.8%-201.0%+15.7%
1M1 Month-+7.4%--
3M3 Months--43.4%-201.0%+15.7%
6M6 Months--32.1%--
YTDYTD--4.2%--
1Y1 Year--38.8%-5.1%+10000.0%
5Y5 Years--+12.0%+100.0%

SPRY PE Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month
3M3-Month
6M6-Month
1Y1-Year194.00132.72
3Y3-Year194.00132.72
5Y5-Year194.00132.72
All-TimeAll-Time194.00132.72

SPRY PE Ratio History

DateValue
DateValue
2024
137.55

FAQ

  • What is the all-time high PE ratio for ARS Pharmaceuticals, Inc.?

What is the all-time high PE ratio for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high price to earnings ratio is 194.00
On this page